Global pharmaceutical firm, Hospira , is now the only company supplying US execution chambers with the paralysis drug used in lethal injections. Pancuronium bromide is the second drug in the lethal injection ‘cocktail’ and serves to paralyse the prisoner before the lethal dose of potassium chloride is administered. Israeli manufacturer, Teva, recently became the latest manufacturer to exit the execution drug trade , leaving Hospira solely responsible for the US supply of the drug. According to expert anaesthesiologist, Dr. Mark Heath, Pancuronium bromide serves no medical purpose in the lethal injection procedure, but rather a ‘cosmetic’ purpose , serving to mask any possible suffering of the inmate. If not properly anesthetised by the first drug in the cocktail, a prisoner will be paralysed by the pancuronium bromide, unable to move, speak or even motion that something has gone wrong. Dr. Heath attests ‘there is no dispute that the asphyxiation caused ...
Striving for a World without Capital Punishment